Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

NCT00443755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Insulin Resistance
Metabolic Syndrome

Interventions

DRUG: metformin
DRUG: pioglitazone
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]
[object Object]